Company registration number 06362832 (England and Wales)
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
CONTENTS
Page
Directors' report
1 - 3
Directors' responsibilities statement
4
Balance sheet
5
Notes to the financial statements
6 - 10
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 1 -
Principal Activities
The principal activity continued to be that of a Local Medical Committee currently recognised under section 97 of the 2006 NHS Act.
Review of the Business
Review of the year by the Chairman
This report is presented at a pivotal time for general practice. It has been both an honour and a responsibility to continue as Chair of Cheshire LMC during a period that may prove decisive for the future of our profession.
The change in government was initially met with genuine optimism. Many hoped it would herald a more constructive relationship with general practice. Regrettably, that optimism has not been realised. Instead, the challenges facing practices have intensified, and the independent contractor model—central to the delivery of primary care—now appears more at risk than at any point in recent history. While there has been no shortage of supportive rhetoric, the actions that have followed have consistently worsened the situation on the ground.
Although the most recent contract settlement was described as a “record” investment, the reality experienced by practices tells a very different story. Escalating and unprecedented cost pressures have rapidly eroded any increases in funding, leaving practices with little to no tangible benefit. This position is unsustainable and has placed GP partners under immense and ongoing strain.
The NHS Long Term Plan could have represented a significant opportunity to reinforce the role of general practice as the backbone of community-based care. Instead, its limited recognition of partnerships and its lack of commitment to strengthening traditional practices have been seen by many as a cause for concern. A shift of care into the community cannot succeed without a robust, well-supported general practice workforce. Equally troubling are recent policy directives concerning online consulting. These measures are perceived by many as overly prescriptive attempts to dictate working patterns. At worst, they risk undermining patient safety by reversing carefully considered steps practices have taken towards safe and sustainable models of care. Such developments cannot be accepted.
This year, Cheshire LMC has taken a principled stance in resisting unfunded work. It is unreasonable and indefensible to expect GPs to absorb uncontracted responsibilities, particularly when these are frequently redirected from other parts of the system that decline them on contractual grounds. This has been a difficult but necessary area of work, and one that has inevitably generated resistance. Nevertheless, the Executive of Cheshire LMC deserves recognition for its perseverance in pursuing this critical issue. Healthcare provision requires appropriate resourcing; GP partners cannot continue to subsidise systemic shortcomings through unpaid work.
The Committee itself has become a vibrant, committed, and forward-thinking body, bringing together clinicians and practice managers with deep expertise and a shared passion for general practice. County meetings are now spirited, solution-focused forums that are both energising and inspiring to chair. Engagement has grown to such an extent that contested elections are now sometimes required for committee seats—a clear sign of the renewed strength and relevance of Cheshire LMC.
Looking ahead, the challenges remain immense, but so too does our commitment. Cheshire LMC will continue to fight for the profession, for our practices, and for our patients. General practice is the foundation of the NHS. It must not be allowed to weaken further. Over the coming 12 months, we will work tirelessly to ensure that the voices of local GPs are heard, respected, and acted upon in this most critical of times.
3 September 2025
Dr David Ward
Chairman
3 September 2025
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
Report by the LMC Medical Director
Over the last year the County-wide LMC members have continued to meet in person and with a virtual option to discuss national contract issues and local hot topics. As the profession is no longer in formal Collective Action with the Government, much of the agenda focused on supporting practices to "Mind the gap", involving local action to address commissioning gaps. Debate did however continue in relation to Safe working, IT, Estates, and local and national policy in relation to the developing neighborhood team agenda. Engagement with NHS England's Cheshire and Merseyside team and senior officers within the C&M ICB and Cheshire Place teams continued. This included engagement with the C&M System Primary Care Committee and Primary Care Advisory Forum, Estates teams, Primary and Secondary Care Interface meetings and Prescribing and Flu groups. We also met senior managers from the two Local Authorities, Public Health and Commissioning Teams in relation to services they commission from GP practices.
Collaboration with PCN CDs, Federations and Cheshire LMC allowed for further development of the Cheshire East and West GP collaborative provider organisations. Similarly, collaboration within the Association of Cheshire and Merseyside LMCs provided a forum to debate issues and influence policy for the benefit of GPs working in the area. This was vital in relation to supporting practices with commissioning and funding gaps.
To ensure our members can stay up to date on the current issues the new CLMC website went live with regular updates added in relation to local and national hot topics. The CLMC WhatsApp group membership remains strong and has been a helpful resource for sharing information quickly with colleagues.
We continued to work with the Cheshire and Merseyside training hub to support the training and retention of GPs in the area. A World Cafe Event for Practice Nurses and a Practice Manager Leadership Programme was commissioned, and webinars were also provided on topics such as pensions and practice finance.
Our focus continues to be on ensuring practices have the resources which are necessary to deliver high quality patient care in an environment where GPs and their teams are valued. To this end we have ensured the voice of our GPs is heard in multiple fora. Please continue to let us know about the issues that concern you.
Thank you to all the GPs, their staff, primary care colleagues and those in partner organisations from Cheshire and beyond who have contacted, supported, and engaged with us over the past year.
3 September 2025
Dr Daniel Harle
Medical Director
3 September 2025
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Dr D G Ward
Dr G R Kent
Dr D Harle
Dr S Tam
Auditor
Afford Bond Holdings Limited were appointed auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.
Statement of disclosure to auditor
So far as the directors are aware, there is no relevant audit information of which the company's auditor are unaware. Additionally, the directors have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company's auditors are aware of that information.
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
By order of the board
3 September 2025
Mr W Greenwood
Secretary
3 September 2025
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the surplus or deficit of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 5 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
15,756
9,786
Current assets
Debtors
5
10,357
36,520
Cash at bank and in hand
136,537
163,606
146,894
200,126
Creditors: amounts falling due within one year
6
(29,684)
(26,787)
Net current assets
117,210
173,339
Net assets
132,966
183,125
Reserves
Income and expenditure account
132,966
183,125
Total members' funds
132,966
183,125
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the income and expenditure account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 3 September 2025 and are signed on its behalf by:
Dr D G Ward
Dr G R Kent
Director
Director
Dr D Harle
Dr S Tam
Director
Director
Company registration number 06362832 (England and Wales)
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025
31 March 2025
- 6 -
1
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
2
Accounting policies
Company information
Cheshire Local Medical Committee Limited is a private company limited by guarantee incorporated in England and Wales. The registered office is c/o Afford Bond Holdings Limited, 31 Wellington Road, Nantwich, Cheshire, CW5 7ED.
2.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
2.2
Income and expenditure
Income and expenses are included in the financial statements as they become receivable or due.
Expenses include VAT where applicable as the company cannot reclaim it.
2.3
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Website costs
25% Reducing balance basis
Chair's badge
Straight line over 178 years
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to surplus or deficit.
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
2
Accounting policies
(Continued)
- 7 -
2.4
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in surplus or deficit, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in surplus or deficit, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
2.5
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
2.6
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
2
Accounting policies
(Continued)
- 8 -
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
2.7
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
2.8
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
2.9
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
2.10
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2.11
Company limited by guarantee
Cheshire Local Medical Committee is a company limited by Guarantee and accordingly does not have issued share capital.
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
3
3
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024
27,731
Additions
9,120
At 31 March 2025
36,851
Depreciation and impairment
At 1 April 2024
17,945
Depreciation charged in the year
3,150
At 31 March 2025
21,095
Carrying amount
At 31 March 2025
15,756
At 31 March 2024
9,786
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
10,357
36,520
6
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
3,650
318
Other creditors
26,034
26,469
29,684
26,787
7
Members' liability
The company is limited by guarantee, not having a share capital and consequently the liability of members is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the company on winding up such amounts as may be required not exceeding £1.
8
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
CHESHIRE LOCAL MEDICAL COMMITTEE LIMITED
(LIMITED BY GUARANTEE)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
8
Audit report information
(Continued)
- 10 -
Opinion
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its deficit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Senior Statutory Auditor:
Paul Edwards FCCA CTA
Statutory Auditor:
Afford Bond Holdings Limited
Date of audit report:
3 September 2025
2025-03-312024-04-01falsefalsefalse03 September 2025CCH SoftwareCCH Accounts Production 2025.200Dr D G WardDr G R KentDr D HarleDr S TamMr W Greenwood063628322024-04-012025-03-31063628322025-03-3106362832bus:Director12024-04-012025-03-3106362832bus:Director22024-04-012025-03-3106362832bus:Director32024-04-012025-03-3106362832bus:Director42024-04-012025-03-3106362832bus:CompanySecretary12024-04-012025-03-31063628322024-03-3106362832core:OtherPropertyPlantEquipment2025-03-3106362832core:OtherPropertyPlantEquipment2024-03-3106362832core:RetainedEarningsAccumulatedLosses2025-03-3106362832core:RetainedEarningsAccumulatedLosses2024-03-3106362832core:ComputerEquipment2024-04-012025-03-3106362832core:MotorVehicles2024-04-012025-03-31063628322023-04-012024-03-3106362832core:OtherPropertyPlantEquipment2024-03-3106362832core:OtherPropertyPlantEquipment2024-04-012025-03-3106362832core:WithinOneYear2025-03-3106362832core:WithinOneYear2024-03-3106362832core:CurrentFinancialInstruments2025-03-3106362832core:CurrentFinancialInstruments2024-03-3106362832bus:CompanyLimitedByGuarantee2024-04-012025-03-3106362832bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3106362832bus:FRS1022024-04-012025-03-3106362832bus:Audited2024-04-012025-03-3106362832bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP